Ibrutinib clinical approach to Mantle Cell Lymphoma at first relapse.
Latest Information Update: 02 Dec 2019
At a glance
- Drugs Ibrutinib (Primary) ; Cytarabine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 02 Dec 2019 New trial record
- 06 Nov 2019 Results assessing the clinical effectiveness and tolerability of Ibrutinib, released in 61st Annual Meeting and Exposition of the American Society of Hematology